Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability
暂无分享,去创建一个
F. Barkhof | A. Thompson | F. Barkhof | C. Polman | M. V. van Walderveen | W. Kamphorst | J. V. van Waesberghe | R. Ravid | J. Castelijns | G. J. Lycklama À Nijeholt | J. Castelijns | C. D. DE GROOT | P. Van Der Valk | G. J. Nijeholt | R. Ravid | A. J. Thompson | P. Van Der Valk | C. J. A. De Groot | C. H. Polman | J. H. T. M. Van Waesberghe | W. Kamphorst | M. A. A. Van Walderveen | J. A. Castelijns | G. J. Lycklama à Nijeholt | C. D. Groot | J. Waesberghe | P. Valk | G. Lycklama à Nijeholt | M. V. Walderveen | A. Thompson | J. V. Waesberghe
[1] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[2] P. Hecke,et al. Human brain proton localized NMR spectroscopy in multiple sclerosis , 1991, Magnetic resonance in medicine.
[3] Hans Lassmann,et al. Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.
[4] H. Tobi,et al. Correlating MRI and clinical disease activity in multiple sclerosis , 1995, Neurology.
[5] W. Mcdonald,et al. The longstanding MS lesion. A quantitative MRI and electron microscopic study. , 1991, Brain : a journal of neurology.
[6] F. Barkhof,et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.
[7] S. Reingold,et al. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. , 1998, Brain : a journal of neurology.
[8] G. Barker,et al. Correlation of magnetization transfer ration with clinical disability in multiple sclerosis , 1994, Annals of neurology.
[9] F. Barkhof,et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis , 1996, Annals of neurology.
[10] A Benazzouz,et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. , 1995, AJNR. American journal of neuroradiology.
[11] F Barkhof,et al. Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions. , 1997, Magnetic resonance imaging.
[12] B. Trapp,et al. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions , 1994, Journal of Neuroimmunology.
[13] P. Sminia,et al. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. , 1999, Journal of neuropathology and experimental neurology.
[14] P M Matthews,et al. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease , 1990, Magnetic resonance in medicine.
[15] Ludwig Kappos,et al. Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis , 1998, The Lancet.
[16] V. Perry,et al. Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.
[17] David H. Miller,et al. A multicenter measurement of magnetization transfer ratio in normal white matter , 1999, Journal of magnetic resonance imaging : JMRI.
[18] Saul A. Teukolsky,et al. Black Holes , 1998 .
[19] C. D. DE GROOT,et al. Immunocytochemical Characterization of the Expression of Inducible and Constitutive Isoforms of Nitric Oxide Synthase in Demyelinating Multiple Sclerosis Lesions , 1997, Journal of neuropathology and experimental neurology.
[20] G. Barker,et al. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis , 1997, Journal of neurology, neurosurgery, and psychiatry.
[21] D. Miller,et al. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon‐β , 1994, Annals of neurology.
[22] F. Barkhof,et al. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis , 1996, Neurology.
[23] Moses Rodriguez,et al. Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis , 1996, Brain pathology.